<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="15100">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00212134</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00024837</org_study_id>
    <secondary_id>U10EY013272</secondary_id>
    <secondary_id>EY013287</secondary_id>
    <secondary_id>EY013272</secondary_id>
    <secondary_id>NEI-108</secondary_id>
    <nct_id>NCT00212134</nct_id>
  </id_info>
  <brief_title>Infant Aphakia Treatment Study (IATS)</brief_title>
  <acronym>IATS</acronym>
  <official_title>Infant Aphakia Treatment Study (IATS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Eye Institute (NEI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>BSN-JOBST Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eye Care and Cure</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Emory University</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <authority>United States: Food and Drug Administration</authority>
    <authority>United States: Data and Safety Monitoring Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose is to determine whether infants with a unilateral congenital cataract
      are more likely to develop better vision following cataract extraction surgery if they
      undergo primary implantation of an intraocular lens or if they are treated primarily with a
      contact lens. In addition, the study will compare the occurrence of postoperative
      complications and the degree of parental stress between the two treatments.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intraocular lenses are now a commonly accepted treatment for cataracts in older children and
      are used increasingly in younger children and infants. Intraocular lenses are superior to
      contact lenses in that they more closely replicate the optics of the crystalline lens, do
      not require daily ongoing care, and ensure at least a partial optical correction at all
      times. The simplicity and improved visual outcome of an intraocular lens correction may make
      caring for a child with a unilateral congenital cataract less stressful for parents.
      However, contact lenses remain the accepted treatment for children under 1 year of age due
      to concerns about the long-term safety of intraocular lenses and the potential for a large
      myopic shift developing in these eyes as they grow. Contact lenses provide excellent visual
      results in infants treated for bilateral congenital cataracts; however, two-thirds of
      infants treated with contact lenses for unilateral congenital cataracts remain legally blind
      in their aphakic eye. These poor visual outcomes are usually ascribed to competition from
      the sound eye and poor compliance with patching and contact lens wear regimens. Data from
      our pilot study and the literature suggest that superior visual results can be obtained if
      an intraocular lens is used to correct unilateral aphakia during infancy, but these eyes
      will experience more complications. Intraocular lenses will be increasingly implanted in
      infants regardless of whether or not we perform this trial. By performing this clinical
      trial, we can determine if the higher rate of complications with intraocular lenses is
      offset by improved visual outcome and decreased parenting stress.

      The Infant Aphakia Treatment Study (IATS) is a multi-center randomized clinical trial
      comparing intraocular lens and contact lens correction for monocular aphakia. Infants will
      be enrolled over a 4 year period. Infants 28 to 210 days of age with a visually significant
      cataract in one eye are eligible. Cataract surgery will be performed in a standardized
      fashion by a surgeon who has been certified for the study. Surgery consists of a lensectomy,
      posterior capsulotomy, and anterior vitrectomy. Infants will be randomized at the time of
      surgery to one of two treatment groups. Infants randomized to the intraocular lens group
      will have an intraocular lens implanted into the capsular bag. Spectacles will subsequently
      be used to correct the residual refractive errors. Infants randomized to the contact lens
      group will be fitted with a contact lens immediately after surgery. Both groups will receive
      the same patching therapy and follow-up. All children will be examined by Investigators at
      fixed intervals using standard protocols with the major endpoint assessed at age 12 months
      by a Traveling Vision Examiner.

      We are currently in a continuation of this project (beyond 5 years) in order to perform
      subjective visual acuity testing at 4.5 years of age and 5 year follow-up vision and ocular
      health exams on all children.

      We will submit a competitive application to be able to have a single visit by the patients
      in this cohort when they reach 10 years of age. This will be past the amblyogenic period and
      permit a more accurate comparative assessment of visual acuity and ocular health between the
      primary intervention groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2004</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>Phase 1 - Age 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Visual acuity was measured by standard objective testing procedures at 12 months of age. Monocular grating acuity was assessed by the traveling examiner with the Teller Acuity Cards. This test uses cards with black-on-white lines of varying widths and a set distance apart in a square with fixed dimensions, so the thinner the lines, the more there will be on any given card (cycles/cm). The ability to see thinner lines indicates better vision. The cards with lines are presented simultaneously with a gray card and the child's visual attention is noted. It is presumed that the child will preferentially look at the card with the stripes as it is more interesting. When the lines are too thin and close together so as to be indistinguishable from the gray card, no preferential looking will be noted. The card with the thinnest lines that the child will look at is recorded as the best visual acuity in logMAR units.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity - Subjective Assessment at Age 4.5 Years.</measure>
    <time_frame>Phase 2 - Age 4.5 Years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Visual acuity estimates were standardized by using the Electronic Visual Acuity Tester (EVAT) at each clinical site. The IATS patients were tested at 4.5 years of age allowing the use of the HOTV recognition acuity test. The Amblyopia Treatment Study protocol for presentation and determination of best corrected visual acuity was followed. Monocular visual acuity was evaluated using single letter optotypes with surround bars presented on the EVAT. The staircase procedure of the ATS projects was followed as this has documented success and reliability with this age group. In order to familiarize the subjects with the HOTV matching test, this test was introduced at the 4.0 year visit and the 4.25 year visit by experienced site personnel.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent of Patients With 1 or More Intraoperative Complications at Cataract Surgery</measure>
    <time_frame>Cataract surgery immediately after enrollment</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of Patients With 1 or More Adverse Events</measure>
    <time_frame>Study enrollment to age 5 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parenting Stress</measure>
    <time_frame>Phase 1 - 3 months post surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>The PSI is a 120-item validated self-report measure of parenting stress. PSI is a continuous scale measuring stress with a range of 131 (low stress) to 320 (high stress); the average person's stress scores are between 188 and 252.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to Occlusion Therapy</measure>
    <time_frame>Phase 1 - 12 months follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>Parental report of the number of hours children wore an patch to occlude the fellow eye.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parenting Stress</measure>
    <time_frame>Phase 1 - Age 12 Months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The PSI is a 120-item validated self-report measure of parenting stress. PSI is a continuous scale measuring stress with a range of 131 (low stress) to 320 (high stress); the average person's stress scores are between 188 and 252</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">114</enrollment>
  <condition>Congenital Cataract</condition>
  <arm_group>
    <arm_group_label>aphakic contact lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>optical correction of infant aphakia with aphakic Contact lens
INTERVENTION: use of an external contact lens (CL) to correct the large hyperopic refractive error produced by surgically extracting the natural cataractous lens. As the eye grows, the refractive error changes and the power of the CL can be changed accordingly.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>aphakic intraocular lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>optical correction of infant aphakia with aphakic Intraocular Lens
INTERVENTION: At the time of surgery to remove the cataractous natural lens, an intraocular lens was implanted to correct the large hyperopic refractive error induced by the cataract surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>hyperopic correction of infant surgical aphakia with Contact Lens</intervention_name>
    <description>optical correction of infant surgical aphakia with Contact lens</description>
    <arm_group_label>aphakic contact lens</arm_group_label>
    <other_name>Silsoft aphakic contact lens</other_name>
    <other_name>rigid gas permeable contact lens</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>primary implantation of aphakic intraocular lens</intervention_name>
    <description>optical correction of surgical aphakia with intraocular lens</description>
    <arm_group_label>aphakic intraocular lens</arm_group_label>
    <other_name>Alcon SA60AT</other_name>
    <other_name>Alcon MA60AC</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Visually significant unilateral congenital cataract (central opacity equal to or
             greater than 3 mm in size).

          -  Cataract surgery performed when the patient is 28 to 210 days of age and at least 41
             post-conceptional weeks.

        Exclusion Criteria:

          -  The cataract is known to be acquired from trauma or as a side-effect of a treatment
             administered postnatally such as radiation or medical therapy.

          -  A corneal diameter less than 9 mm measured in the horizontal meridian using calipers.

          -  An intraocular pressure of 25 mm Hg or greater in the affected eye measured with a
             Perkins tonometer, tonopen, or pneumatonometer.

          -  Persistent fetal vasculature (PFV) causing stretching of the ciliary processes or a
             tractional retinal detachment.

          -  Active uveitis or signs suggestive of a previous episode of uveitis such as posterior
             synechiae or keratic precipitates.

          -  The child is the product of a pre-term pregnancy (&lt;36 gestational weeks). Screening
             for prematurity will be based on the clinician's best assessment of gestational age.
             If a physician is uncertain regarding the gestational age, review of medical records
             or contact with the pediatrician and/or obstetrician should be used to confirm
             gestational age at delivery. Unless a clinician is uncertain as to whether a child
             was born at less than 36 weeks or not, confirmation of gestational age via medical
             record review may be delayed until after enrollment.

          -  Retinal disease that may limit the visual potential of the eye such as retinopathy of
             prematurity.

          -  Previous intraocular surgery.

          -  Optic nerve disease that may limit the visual potential of the eye such as optic
             nerve hypoplasia.

          -  The fellow eye has ocular disease that might reduce its visual potential.

          -  The child has a medical condition known to limit the ability to obtain visual acuity
             at 12 months or 4 years of age.

          -  Refusal by the Parent/Legal Guardian to sign an informed consent or to be randomized
             to one of the two treatment groups.

          -  Follow-up of the child is not feasible because the child would not be able to return
             for regular follow-up examinations and the outcome assessments (e.g. transportation
             difficulties, relocation, etc.).
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>210 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott Lambert, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Emory University Eye Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Miami Children's Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33155</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory Eye Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University Medical Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202-5175</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harvard University</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455-0501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Eye Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239-4197</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425-2236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232-8808</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pediatric Ophthalmology, P.A.</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor University</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.nei.nih.gov/health/clinicalstudies/</url>
    <description>NEI Clinical Studies Database--Infant Aphakia Treatment Study (IATS)</description>
  </link>
  <link>
    <url>http://web1.sph.emory.edu/IATS</url>
    <description>Infant Aphakia Treatment Study (IATS)</description>
  </link>
  <verification_date>February 2015</verification_date>
  <lastchanged_date>February 6, 2015</lastchanged_date>
  <firstreceived_date>September 13, 2005</firstreceived_date>
  <firstreceived_results_date>July 15, 2013</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Emory University</investigator_affiliation>
    <investigator_full_name>Scott R Lambert, MD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>cataract surgery</keyword>
  <keyword>intraocular lens</keyword>
  <keyword>contact lens</keyword>
  <keyword>infants</keyword>
  <keyword>aphakia</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment 12/23/04 to 01/16/09 at 12 medical clinics.</recruitment_details>
      <pre_assignment_details>Final eligibility determined at pre-operative ocular examination under anesthesia.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Aphakic Contact Lens</title>
          <description>optical correction of infant aphakia with aphakic Contact lens
INTERVENTION: aphakic contact lens</description>
        </group>
        <group group_id="P2">
          <title>Aphakic Intraocular Lens</title>
          <description>optical correction of infant aphakia with aphakic Intraocular Lens
INTERVENTION: aphakic intraocular lens</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Phase 1 (to Age 1 Year)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="57"/>
                <participants group_id="P2" count="57"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Complete First Endpoint at 1 Year</title>
              <participants_list>
                <participants group_id="P1" count="57"/>
                <participants group_id="P2" count="57"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="57">Age 1 data collection visit</participants>
                <participants group_id="P2" count="57">Age 1 data collection visit</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Phase 2 (Age 1 Year to Age 5 Years)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="57">Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.</participants>
                <participants group_id="P2" count="57">Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="57"/>
                <participants group_id="P2" count="56">Patient lost to follow-up.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Aphakic Contact Lens</title>
          <description>optical correction of infant aphakia with aphakic Contact lens
INTERVENTION: aphakic contact lens</description>
        </group>
        <group group_id="B2">
          <title>Aphakic Intraocular Lens</title>
          <description>optical correction of infant aphakia with aphakic Intraocular Lens
INTERVENTION: aphakic intraocular lens</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="57"/>
                <measurement group_id="B2" value="57"/>
                <measurement group_id="B3" value="114"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>months</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <sub_title>mean/sd</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="2.4" spread="1.6"/>
                <measurement group_id="B2" value="2.5" spread="1.6"/>
                <measurement group_id="B3" value="2.5" spread="1.6"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>28 - 48 days</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="25"/>
                <measurement group_id="B2" value="25"/>
                <measurement group_id="B3" value="50"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>49 days - 3.0 months</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="17"/>
                <measurement group_id="B2" value="15"/>
                <measurement group_id="B3" value="32"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>3.1 - 5.0 months</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="9"/>
                <measurement group_id="B2" value="10"/>
                <measurement group_id="B3" value="19"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>5.1 - 6.8 months</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="6"/>
                <measurement group_id="B2" value="7"/>
                <measurement group_id="B3" value="13"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="32"/>
                <measurement group_id="B2" value="28"/>
                <measurement group_id="B3" value="60"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="25"/>
                <measurement group_id="B2" value="29"/>
                <measurement group_id="B3" value="54"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Hispanic or Latino</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="9"/>
                <measurement group_id="B2" value="10"/>
                <measurement group_id="B3" value="19"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Not Hispanic or Latino</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="48"/>
                <measurement group_id="B2" value="47"/>
                <measurement group_id="B3" value="95"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Unknown or Not Reported</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>American Indian or Alaska Native</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="1"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="1"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Asian</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="2"/>
                <measurement group_id="B2" value="1"/>
                <measurement group_id="B3" value="3"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Native Hawaiian or Other Pacific Islander</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Black or African American</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="3"/>
                <measurement group_id="B2" value="5"/>
                <measurement group_id="B3" value="8"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>White</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="49"/>
                <measurement group_id="B2" value="48"/>
                <measurement group_id="B3" value="97"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>More than one race</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="3"/>
                <measurement group_id="B3" value="3"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Unknown or Not Reported</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="2"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="2"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="57"/>
                <measurement group_id="B2" value="57"/>
                <measurement group_id="B3" value="114"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Private Insurance</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>No</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="20"/>
                <measurement group_id="B2" value="24"/>
                <measurement group_id="B3" value="44"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Yes</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="37"/>
                <measurement group_id="B2" value="33"/>
                <measurement group_id="B3" value="70"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Qualified for Medicaid</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>No</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="40"/>
                <measurement group_id="B2" value="35"/>
                <measurement group_id="B3" value="75"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Yes</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="17"/>
                <measurement group_id="B2" value="22"/>
                <measurement group_id="B3" value="39"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Pupil Diameter - Cataractous Eye</title>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="3.3" spread="1.0"/>
                <measurement group_id="B2" value="3.2" spread="1.0"/>
                <measurement group_id="B3" value="3.3" spread="1.0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Pupil Diameter - Fellow Eye</title>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="3.5" spread="0.9"/>
                <measurement group_id="B2" value="3.4" spread="0.9"/>
                <measurement group_id="B3" value="3.4" spread="0.9"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Corneal Diameter - Cataractous Eye</title>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="10.5" spread="0.7"/>
                <measurement group_id="B2" value="10.5" spread="0.8"/>
                <measurement group_id="B3" value="10.5" spread="0.7"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Corneal Diameter - Fellow Eye</title>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="10.8" spread="0.6"/>
                <measurement group_id="B2" value="10.8" spread="0.7"/>
                <measurement group_id="B3" value="10.8" spread="0.6"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Intraocular Pressure - Cataractous Eye</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="12.7" spread="4.9"/>
                <measurement group_id="B2" value="11.8" spread="4.9"/>
                <measurement group_id="B3" value="12.2" spread="4.9"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Intraocular Pressure - Fellow Eye</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="12.8" spread="5.1"/>
                <measurement group_id="B2" value="12.9" spread="4.3"/>
                <measurement group_id="B3" value="12.9" spread="4.7"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Keratometric Power - Cataractous Eye</title>
          <units>diopters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="46.4" spread="2.7"/>
                <measurement group_id="B2" value="46.4" spread="2.7"/>
                <measurement group_id="B3" value="46.4" spread="2.7"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Keratometric Power - Fellow Eye</title>
          <units>diopters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="45.5" spread="1.8"/>
                <measurement group_id="B2" value="45.4" spread="1.9"/>
                <measurement group_id="B3" value="45.5" spread="1.8"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Axial Length - Cataractous Eye</title>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="18.0" spread="1.3"/>
                <measurement group_id="B2" value="18.1" spread="1.3"/>
                <measurement group_id="B3" value="18.0" spread="1.3"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Axial Length - Fellow Eye</title>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="18.4" spread="0.9"/>
                <measurement group_id="B2" value="18.7" spread="0.9"/>
                <measurement group_id="B3" value="18.6" spread="0.9"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Refractive Error - Fellow Eye</title>
          <description>Spherical equivalent of the refraction measured under cycloplegia</description>
          <units>diopters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="2.4" spread="1.8"/>
                <measurement group_id="B2" value="2.3" spread="2.2"/>
                <measurement group_id="B3" value="2.3" spread="2.0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity</title>
        <description>Visual acuity was measured by standard objective testing procedures at 12 months of age. Monocular grating acuity was assessed by the traveling examiner with the Teller Acuity Cards. This test uses cards with black-on-white lines of varying widths and a set distance apart in a square with fixed dimensions, so the thinner the lines, the more there will be on any given card (cycles/cm). The ability to see thinner lines indicates better vision. The cards with lines are presented simultaneously with a gray card and the child's visual attention is noted. It is presumed that the child will preferentially look at the card with the stripes as it is more interesting. When the lines are too thin and close together so as to be indistinguishable from the gray card, no preferential looking will be noted. The card with the thinnest lines that the child will look at is recorded as the best visual acuity in logMAR units.</description>
        <time_frame>Phase 1 - Age 12 months</time_frame>
        <safety_issue>No</safety_issue>
        <population>The number of participants was determined by the sample size estimate necessary to detect a 0.2 logMAR difference (2 lines on the Snellen chart) in the visual acuity between the two groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Aphakic Contact Lens</title>
            <description>optical correction of infant aphakia with aphakic Contact lens
INTERVENTION: use of an external contact lens (CL) to correct the large hyperopic refractive error produced by surgically extracting the natural cataractous lens. As the eye grows, the refractive error changes and the power of the CL can be changed accordingly.</description>
          </group>
          <group group_id="O2">
            <title>Aphakic Intraocular Lens</title>
            <description>optical correction of infant aphakia with aphakic Intraocular Lens
INTERVENTION: The refractive error induced by surgical removal of the cataractous natural lens is partially corrected by the implantation of an intraocular lens (IOL) at the time of surgery. This is deemed a permanent correction as the IOL may only be removed in a subsequent surgery.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="57"/>
                  <measurement group_id="O2" value="57"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Visual Acuity</title>
            <description>Visual acuity was measured by standard objective testing procedures at 12 months of age. Monocular grating acuity was assessed by the traveling examiner with the Teller Acuity Cards. This test uses cards with black-on-white lines of varying widths and a set distance apart in a square with fixed dimensions, so the thinner the lines, the more there will be on any given card (cycles/cm). The ability to see thinner lines indicates better vision. The cards with lines are presented simultaneously with a gray card and the child's visual attention is noted. It is presumed that the child will preferentially look at the card with the stripes as it is more interesting. When the lines are too thin and close together so as to be indistinguishable from the gray card, no preferential looking will be noted. The card with the thinnest lines that the child will look at is recorded as the best visual acuity in logMAR units.</description>
            <units>logMAR units</units>
            <param>Median</param>
            <dispersion>Inter-Quartile Range</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0.80" lower_limit="0.66" upper_limit="0.97"/>
                  <measurement group_id="O2" value="0.97" lower_limit="0.80" upper_limit="1.10"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.19</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent of Patients With 1 or More Intraoperative Complications at Cataract Surgery</title>
        <time_frame>Cataract surgery immediately after enrollment</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Aphakic Contact Lens</title>
            <description>optical correction of infant aphakia with aphakic Contact lens
INTERVENTION: use of an external contact lens (CL) to correct the large hyperopic refractive error produced by surgically extracting the natural cataractous lens. As the eye grows, the refractive error changes and the power of the CL can be changed accordingly.
hyperopic correction of infant surgical aphakia with Contact Lens: optical correction of infant surgical aphakia with Contact lens</description>
          </group>
          <group group_id="O2">
            <title>Aphakic Intraocular Lens</title>
            <description>optical correction of infant aphakia with aphakic Intraocular Lens
INTERVENTION: At the time of surgery to remove the cataractous natural lens, an intraocular lens was implanted to correct the large hyperopic refractive error induced by the cataract surgery.
primary implantation of aphakic intraocular lens: optical correction of surgical aphakia with intraocular lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="57"/>
                  <measurement group_id="O2" value="57"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Percent of Patients With 1 or More Intraoperative Complications at Cataract Surgery</title>
            <units>percentage of patients</units>
            <param>Number</param>
            <dispersion>95% Confidence Interval</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="11" lower_limit="4" upper_limit="22"/>
                  <measurement group_id="O2" value="28" lower_limit="17" upper_limit="42"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.03</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity - Subjective Assessment at Age 4.5 Years.</title>
        <description>Visual acuity estimates were standardized by using the Electronic Visual Acuity Tester (EVAT) at each clinical site. The IATS patients were tested at 4.5 years of age allowing the use of the HOTV recognition acuity test. The Amblyopia Treatment Study protocol for presentation and determination of best corrected visual acuity was followed. Monocular visual acuity was evaluated using single letter optotypes with surround bars presented on the EVAT. The staircase procedure of the ATS projects was followed as this has documented success and reliability with this age group. In order to familiarize the subjects with the HOTV matching test, this test was introduced at the 4.0 year visit and the 4.25 year visit by experienced site personnel.</description>
        <time_frame>Phase 2 - Age 4.5 Years</time_frame>
        <safety_issue>No</safety_issue>
        <population>One patient in the intraocular lens group was lost to follow-up.at age 18 months. A second patient in that group had developmental delay and the visual acuity could not be assessed. Therefore, the visual acuity measurements at 4.5 years of age are reported for 55 of the 57 patients randomized to the intraocular lens group.</population>
        <group_list>
          <group group_id="O1">
            <title>Aphakic Contact Lens</title>
            <description>optical correction of infant aphakia with aphakic Contact lens
INTERVENTION: aphakic contact lens</description>
          </group>
          <group group_id="O2">
            <title>Aphakic Intraocular Lens</title>
            <description>optical correction of infant aphakia with aphakic Intraocular Lens
INTERVENTION: aphakic intraocular lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="57"/>
                  <measurement group_id="O2" value="55"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Visual Acuity - Subjective Assessment at Age 4.5 Years.</title>
            <description>Visual acuity estimates were standardized by using the Electronic Visual Acuity Tester (EVAT) at each clinical site. The IATS patients were tested at 4.5 years of age allowing the use of the HOTV recognition acuity test. The Amblyopia Treatment Study protocol for presentation and determination of best corrected visual acuity was followed. Monocular visual acuity was evaluated using single letter optotypes with surround bars presented on the EVAT. The staircase procedure of the ATS projects was followed as this has documented success and reliability with this age group. In order to familiarize the subjects with the HOTV matching test, this test was introduced at the 4.0 year visit and the 4.25 year visit by experienced site personnel.</description>
            <units>logMAR units</units>
            <param>Median</param>
            <dispersion>Inter-Quartile Range</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0.90" lower_limit="0.30" upper_limit="1.60"/>
                  <measurement group_id="O2" value="0.90" lower_limit="0.40" upper_limit="1.73"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.54</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent of Patients With 1 or More Adverse Events</title>
        <time_frame>Study enrollment to age 5 years</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Aphakic Contact Lens</title>
            <description>optical correction of infant aphakia with aphakic Contact lens
INTERVENTION: aphakic contact lens</description>
          </group>
          <group group_id="O2">
            <title>Aphakic Intraocular Lens</title>
            <description>optical correction of infant aphakia with aphakic Intraocular Lens
INTERVENTION: aphakic intraocular lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="57"/>
                  <measurement group_id="O2" value="57"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Percent of Patients With 1 or More Adverse Events</title>
            <units>percentage of patients</units>
            <param>Number</param>
            <dispersion>95% Confidence Interval</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="56" lower_limit="42" upper_limit="69"/>
                  <measurement group_id="O2" value="81" lower_limit="68" upper_limit="90"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.008</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Parenting Stress</title>
        <description>The PSI is a 120-item validated self-report measure of parenting stress. PSI is a continuous scale measuring stress with a range of 131 (low stress) to 320 (high stress); the average person's stress scores are between 188 and 252.</description>
        <time_frame>Phase 1 - 3 months post surgery</time_frame>
        <safety_issue>No</safety_issue>
        <population>All those who completed the PSI 3 months after surgery.</population>
        <group_list>
          <group group_id="O1">
            <title>Aphakic Contact Lens</title>
            <description>optical correction of infant aphakia with aphakic Contact lens
INTERVENTION: aphakic contact lens</description>
          </group>
          <group group_id="O2">
            <title>Aphakic Intraocular Lens</title>
            <description>optical correction of infant aphakia with aphakic Intraocular Lens
INTERVENTION: aphakic intraocular lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="55"/>
                  <measurement group_id="O2" value="53"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Parenting Stress</title>
            <description>The PSI is a 120-item validated self-report measure of parenting stress. PSI is a continuous scale measuring stress with a range of 131 (low stress) to 320 (high stress); the average person's stress scores are between 188 and 252.</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="197.4" spread="35.7"/>
                  <measurement group_id="O2" value="231.1" spread="36.8"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>ITT analyses comparing parents of children randomized to receive an IOL to those left aphakic.</groups_desc>
            <non_inferiority>No</non_inferiority>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>15.7</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adherence to Occlusion Therapy</title>
        <description>Parental report of the number of hours children wore an patch to occlude the fellow eye.</description>
        <time_frame>Phase 1 - 12 months follow-up</time_frame>
        <safety_issue>No</safety_issue>
        <population>Analysis is limited to those with at least 3 reports of adherence before 12 months of age.</population>
        <group_list>
          <group group_id="O1">
            <title>Aphakic Contact Lens</title>
            <description>optical correction of infant aphakia with aphakic Contact lens
INTERVENTION: aphakic contact lens</description>
          </group>
          <group group_id="O2">
            <title>Aphakic Intraocular Lens</title>
            <description>optical correction of infant aphakia with aphakic Intraocular Lens
INTERVENTION: aphakic intraocular lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="53"/>
                  <measurement group_id="O2" value="53"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Adherence to Occlusion Therapy</title>
            <description>Parental report of the number of hours children wore an patch to occlude the fellow eye.</description>
            <units>Hours patched per day</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="3.92" spread="1.55"/>
                  <measurement group_id="O2" value="3.63" spread="1.68"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Parenting Stress</title>
        <description>The PSI is a 120-item validated self-report measure of parenting stress. PSI is a continuous scale measuring stress with a range of 131 (low stress) to 320 (high stress); the average person's stress scores are between 188 and 252</description>
        <time_frame>Phase 1 - Age 12 Months</time_frame>
        <safety_issue>No</safety_issue>
        <population>All those who completed the PSI 3 months after surgery and the PSI at age 12 months</population>
        <group_list>
          <group group_id="O1">
            <title>Aphakic Contact Lens</title>
            <description>optical correction of infant aphakia with aphakic Contact lens
INTERVENTION: aphakic contact lens</description>
          </group>
          <group group_id="O2">
            <title>Aphakic Intraocular Lens</title>
            <description>optical correction of infant aphakia with aphakic Intraocular Lens
INTERVENTION: aphakic intraocular lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="43"/>
                  <measurement group_id="O2" value="38"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Parenting Stress</title>
            <description>The PSI is a 120-item validated self-report measure of parenting stress. PSI is a continuous scale measuring stress with a range of 131 (low stress) to 320 (high stress); the average person's stress scores are between 188 and 252</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="202.6" spread="34.4"/>
                  <measurement group_id="O2" value="208.3" spread="30.8"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>ITT comparison of mean PSI scores</groups_desc>
            <non_inferiority>No</non_inferiority>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>7.295</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Ocular adverse events occurring the day after enrollment until the follow-up visit at 5 years of age are reported.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Aphakic Contact Lens</title>
          <description>optical correction of infant aphakia with aphakic Contact lens
INTERVENTION: aphakic contact lens</description>
        </group>
        <group group_id="E2">
          <title>Aphakic Intraocular Lens</title>
          <description>optical correction of infant aphakia with aphakic Intraocular Lens
INTERVENTION: aphakic intraocular lens</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_vocab>Standard Terminology</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="32" subjects_at_risk="57"/>
                <counts group_id="E2" subjects_affected="46" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Lens reproliferation into visual axis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="57"/>
                <counts group_id="E2" events="23" subjects_affected="23" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Pupillary membrane</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="57"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Corectopia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="57"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="57"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Glaucoma suspect</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="57"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Contact lens related adverse event</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="57"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Vitreous hemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="57"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Retinal hemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="57"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Hyphema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="57"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Retained cortex</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="57"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="57"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Endophthalmitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="57"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Phthisis bulbi</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="57"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Corneal edema lasting more than 30 days</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Wound leak or dehisence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Intraocular lens capture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Scott R Lambert, MD, Study Chairman</name_or_title>
      <organization>Emory School of Medicine</organization>
      <phone>404-778-3709</phone>
      <email>slamber@emory.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
